LAMAs were largely prescribed for patients in Turkey who had uncontrolled asthma, older age, obesity, exacerbations, and/or worse lung function.

Current maintenance or controller treatments for COPD include tiotropoium, LAMA, LABA, LABA + ICS, LAMA + LABA, roflumilast, theophylline, and 'triple therapy' combining LAMA + LABA + ICS.

Inhaled corticosteroids (ICS), short- and long-acting β 2-agonists (SABA and LABA), long-acting muscarinic antagonists (LAMA) and fixed-dose combinations of LABA and ICS are the cornerstones of ...

In the study Spiolto - which combines tiotropium, the active ingredient in Boehringer's LAMA drug Spiriva with LABA olodaterol - demonstrated a 42 percent improved in a key measure of lung ...

The remaining treatments were prescribed to smaller proportions of patients, with 19% prescribed a long-acting muscarinic antagonist, 18% prescribed LAMA/LABA, 10% prescribed LAMA/LABA/ICS via a ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

Enerzair (formerly QVM149) consists of long-acting beta agonist (LABA) indacaterol, long-acting muscarinic antagonist (LAMA) glycopyrronium, and inhaled corticosteroid (ICS) mometasone furoate ...